PE20040770A1 - Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer - Google Patents

Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer

Info

Publication number
PE20040770A1
PE20040770A1 PE2003001247A PE2003001247A PE20040770A1 PE 20040770 A1 PE20040770 A1 PE 20040770A1 PE 2003001247 A PE2003001247 A PE 2003001247A PE 2003001247 A PE2003001247 A PE 2003001247A PE 20040770 A1 PE20040770 A1 PE 20040770A1
Authority
PE
Peru
Prior art keywords
alkyl
inhibitors
compounds
alzheimer
disease
Prior art date
Application number
PE2003001247A
Other languages
English (en)
Spanish (es)
Inventor
Thierry Canton
Laurent Pradier
Jesus Benavides
Hubert Heuer
Hans-Ludwig Schaefer
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PE20040770A1 publication Critical patent/PE20040770A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PE2003001247A 2002-12-12 2003-12-10 Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer PE20040770A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0215722A FR2848452B1 (fr) 2002-12-12 2002-12-12 Application des inhibiteurs de recapture intestinale des acides biliaires pour la prevention et le traitement de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
PE20040770A1 true PE20040770A1 (es) 2004-12-10

Family

ID=32338722

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003001247A PE20040770A1 (es) 2002-12-12 2003-12-10 Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer

Country Status (22)

Country Link
EP (1) EP1572174A1 (ko)
JP (1) JP2006514063A (ko)
KR (1) KR20050084250A (ko)
CN (1) CN1726016A (ko)
AR (1) AR042354A1 (ko)
AU (1) AU2003296802A1 (ko)
BR (1) BR0317280A (ko)
CA (1) CA2507945A1 (ko)
CO (1) CO5700712A2 (ko)
FR (1) FR2848452B1 (ko)
HR (1) HRP20050534A2 (ko)
MA (1) MA27500A1 (ko)
MX (1) MXPA05005556A (ko)
NO (1) NO20053341L (ko)
NZ (1) NZ540496A (ko)
PE (1) PE20040770A1 (ko)
PL (1) PL377110A1 (ko)
RS (1) RS20050420A (ko)
RU (1) RU2005121909A (ko)
TW (1) TW200503707A (ko)
WO (1) WO2004062652A1 (ko)
ZA (1) ZA200504656B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
ZA200603165B (en) 2003-11-03 2007-07-25 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
KR101099206B1 (ko) 2004-02-05 2011-12-27 프로비오드룩 아게 신규한 글루타미닐 시클라제 저해제
CA2589102C (en) 2004-11-02 2013-08-13 Northwestern University Pyridazine compounds and methods for using the compounds to treat inflammatory diseases
EP2015750A2 (en) 2006-04-28 2009-01-21 Northwestern University Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
WO2008143361A1 (en) * 2007-05-22 2008-11-27 Otsuka Pharmaceutical Co., Ltd. A medicament comprising a carbostyril derivative and donepezil for treating alzheimer's disease
BR112014010228B1 (pt) * 2011-10-28 2020-09-29 Lumena Pharmaceuticals Llc Uso de inibidores de reciclagem de ácido biliar para o tratamento de hipercolemia e doença hepática colestática
PL2771003T3 (pl) 2011-10-28 2017-10-31 Lumena Pharmaceuticals Llc Inhibitory ponownego wykorzystania kwasów żółciowych do leczenia pediatrycznych cholestatycznych chorób wątroby

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2040996A1 (en) * 1990-05-02 1991-11-03 Robert L. Albright Composition and method for controlling cholesterol
CA2104594C (en) * 1991-02-22 2004-05-11 Howard K. Shapiro Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology
WO1997049387A1 (en) * 1996-06-27 1997-12-31 G.D. Searle And Co. Particles comprising amphiphilic copolymers, having a cross-linked shell domain and an interior core domain, useful for pharmaceutical and other applications
US5985936A (en) * 1997-12-18 1999-11-16 Forbes Medi-Tech, Inc. Method of preventing and delaying onset of Alzheimer's disease and composition therefor
JP2002501887A (ja) * 1998-01-28 2002-01-22 ワーナー−ランバート・カンパニー アルツハイマー病の治療方法
US6080778A (en) * 1998-03-23 2000-06-27 Children's Medical Center Corporation Methods for decreasing beta amyloid protein
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19825804C2 (de) * 1998-06-10 2000-08-24 Aventis Pharma Gmbh 1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19845405C2 (de) * 1998-10-02 2000-07-13 Aventis Pharma Gmbh Arylsubstituierte Propanolaminderivate und deren Verwendung
US20010028895A1 (en) * 2000-02-04 2001-10-11 Bisgaier Charles L. Methods of treating alzheimer's disease
US20020028826A1 (en) * 2000-06-15 2002-03-07 Robl Jeffrey A. HMG-CoA reductase inhibitors and method
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
TWI329111B (en) * 2002-05-24 2010-08-21 X Ceptor Therapeutics Inc Azepinoindole and pyridoindole derivatives as pharmaceutical agents

Also Published As

Publication number Publication date
KR20050084250A (ko) 2005-08-26
JP2006514063A (ja) 2006-04-27
FR2848452B1 (fr) 2007-04-06
BR0317280A (pt) 2005-11-08
CN1726016A (zh) 2006-01-25
TW200503707A (en) 2005-02-01
AR042354A1 (es) 2005-06-15
NO20053341D0 (no) 2005-07-08
CO5700712A2 (es) 2006-11-30
NO20053341L (no) 2005-09-07
AU2003296802A1 (en) 2004-08-10
WO2004062652A1 (fr) 2004-07-29
CA2507945A1 (fr) 2004-07-29
MA27500A1 (fr) 2005-08-01
NZ540496A (en) 2008-04-30
HRP20050534A2 (en) 2006-11-30
RU2005121909A (ru) 2006-01-20
EP1572174A1 (fr) 2005-09-14
RS20050420A (en) 2007-04-10
MXPA05005556A (es) 2005-07-26
FR2848452A1 (fr) 2004-06-18
ZA200504656B (en) 2006-08-30
PL377110A1 (pl) 2006-01-23

Similar Documents

Publication Publication Date Title
PE20040770A1 (es) Aplicacion de inhibidores de recaptura intestinal de acido biliar para la prevencion y el tratamiento de la enfermedad de alzheimer
TW200833319A (en) Crystalline forms
UA101601C2 (uk) Інгібітори амідогідролази жирних кислот
AR039672A1 (es) Dipeptido, derivado de benzotiazepina. inhibidor del transporte ileal de acidos biliares (ibat)
PE20121314A1 (es) Derivados de 4-aminociclohexano sustituido
MX339144B (es) Nuevas drogas para inhibir la agregacion de proteinas involucradas en enfermedades relacionadas con la agregacion de proteinas y/o enfermedades neurodegenerativas.
WO2008002573A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
PE20081389A1 (es) Uso de profarmacos de analogos de gaba para tratar enfermedades
CA2601808A1 (en) Use of macelignan for treatment of brain diseases
TW200806299A (en) Treatment of pain
MY143568A (en) 11b-hsd1 inhibitors for the treatment of diabetes
RU2005105576A (ru) Производные плевромутилина в качестве противомикроюных средств
CU24030B1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen
PE20080364A1 (es) Acido bifenilcarboxilicos substituidos y sus derivados como moduladores de la actividad de la gamma-secretasa
CA2472335A1 (en) Geranyl compounds
TW200604173A (en) Novel compounds
ES2278552T1 (es) Preparacion de intermediarios de tadalafil.
CN107709314A (zh) 外排泵抑制剂及其治疗性用途
AR033300A1 (es) Compuestos de cefem
RU2009122481A (ru) Эффективный способ получения соединений мугеиновой кислоты
NO20092382L (no) Radioaktivt diagnostiserende avbildningsmiddel
ZA200805740B (en) Novel polyunsaturated compounds, method for preparing same and compositions containing same
MX2009012297A (es) Composiciones para el tratamiento de enfermedad alergica, con compuestos inmunoreguladores.
DE69623610D1 (de) Neue heterozyklische chemie
AR065724A1 (es) Macrolidos

Legal Events

Date Code Title Description
FC Refusal